Floatz logo

MIDAZOLAM

Seizure Disorder Generalized Tonic Clonic

Pakistan Air Force (PAF) Hospital IslamabadSmall moleculePhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Seizure Disorder Generalized Tonic Clonic cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
GlaxoSmithKline
Phase 4BBB
Topamax
GlaxoSmithKline
Phase 3BB
Keppra
Emory University
Phase 4BB
Pregabalin
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3BB
Zonisamide
Affiliated Hospital of Nantong University
Phase 4B

View all 12 →

Same molecule, other indications

MIDAZOLAM is also rated in:

gastrointestinal stromal tumorDormant
BBB
Indicative ·
75 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
75 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →